Home › Funds › Duquesne Family Office LLC › BEAM
Duquesne Family Office LLC position in BEAM
BEAM THERAPEUTICS INC · Health Care
Duquesne Family Office LLC reported holding 699,700 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$17.1M, representing 0.45% of its reported portfolio and ranking #38 among its reported holdings. Duquesne Family Office LLC has disclosed BEAM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Duquesne Family Office LLC's BEAM position evolved
Duquesne Family Office LLC first disclosed a stake in BEAM in Q2 2026 at 153,600 shares (US$5.3M). The position peaked in Q3 2026 at 699,700 shares, worth US$17.1M. Across 2 filings, Duquesne Family Office LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 699,700 shares valued at US$17.1M — an increase of 546,100 shares quarter over quarter.. Notable position changes include a 356% increase in Q3 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 153.60K | $5.27M | New |
| Q3 2026 | 699.70K | $17.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), ARK Invest (US$288.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$251.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 11.81M sh · $288.64M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.28M sh · $251.26M · Q3 2026
- ARCH Venture Management, LLC 4.54M sh · $111.01M · Q3 2026
- Kynam Capital Management, LP 3.93M sh · $96.18M · Q3 2026
- Amova Asset Management Americas, Inc. 3.35M sh · $81.76M · Q3 2026
- Casdin Capital 1.50M sh · $36.67M · Q3 2026
- Redmile Group, LLC 1.06M sh · $25.96M · Q3 2026
More on Duquesne Family Office LLC
FAQ
How long has Duquesne Family Office LLC held BEAM?
Duquesne Family Office LLC has disclosed BEAM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Duquesne Family Office LLC's current position in BEAM?
As of Q3 2026, Duquesne Family Office LLC holds 699.70K shares of BEAM (BEAM THERAPEUTICS INC), valued at $17.11M, representing 0.45% of its reported portfolio and ranking #38.
Has Duquesne Family Office LLC been buying or selling BEAM?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC increased its position in BEAM. The position peaked in Q3 2026 at 699.70K shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include Farallon Capital Management, ARK Invest, FARALLON CAPITAL MANAGEMENT, L.L.C., among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.